Accurate detection of outliers and subpopulations with pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R

Therapeutic Drug Monitoring

Volumn 34, Issue 4, 2012, Pages 467-476

  Neely, Michael N ^a   Van Guilder, Michael G ^a   Yamada, Walter M ^a   Schumitzky, Alan ^a   Jelliffe, Roger W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

nonparametric; pharmacometrics; population modeling; R; software

Indexed keywords

INFUSION FLUID;

ARTICLE; BAYESIAN LEARNING; COMPARTMENT MODEL; COMPUTER PROGRAM; DIAGNOSIS RELATED GROUP; HUMAN; NONPARAMETRIC TEST; PARAMETRIC TEST; PHARMACODYNAMICS; PHARMACOMETRICS; POPULATION MODEL; PRIORITY JOURNAL; RELIABILITY;

ALGORITHMS; BAYES THEOREM; DRUG MONITORING; MODELS, BIOLOGICAL; PHARMACOKINETICS; SOFTWARE;

EID: 84863817675     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31825c4ba6     Document Type: Article

References (17)

1. Barrett JS, Fossler MJ, Cadieu KD, et al. Pharmacometrics: a multidisciplinary field to facilitate critical thinking in drug development and translational research settings. J Clin Pharmacol. 2008;48:632-649. (Pubitemid 351503519)
2. Neely M, Jelliffe R. Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometrician. J Clin Pharmacol. 2010;50: 842-847.
3. Neely M, Jelliffe R. Practical therapeutic drug management in HIV-infected patients: use of population pharmacokinetic models supplemented by individualized Bayesian dose optimization. J Clin Pharmacol. 2008;48:1081-1091.
4. Schumitzky A. Nonparametric EM algorithms for estimating prior distributions. Appl Math Comput. 1991;45:141-157.
5. Baek Y. An interior point approach to constrained nonparametric mixture models. PhD dissertation. Seattle, Washington: University of Washington, Department of Mathematics (2006).
6. Bustad A, Terziivanov D, Leary R, et al. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies. Clin Pharmacokinet. 2006;45:365-383.
7. Kiefer J, Wolfowitz J. Consistency of the maximum likelihood estimator in the presence of infinitely many incidental parameters. Ann Math Stat. 1956;27:887-906.
8. Mallet A. A maximum likelihood estimation method for random coefficient regression models. Biometrika. 1986;73:645-656.
9. Jelliffe R, Bayard D, Milman M, et al. Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens. Ther Drug Monit. 2000;22:346-353. (Pubitemid 30346453)
10. Bayard DS. A forward method for optimal stochastic nonlinear and adaptive control. Auto Con IEEE Trans. 1991;36:1046-1053.
11. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, R project. 2011. Available at: http://www.R-project.org/. Accessed December 14, 2011.
12. Neely M. Pmetrics User's Manual. University of Southern California Laboratory of Applied Pharmacokinetics. Available at: http://www.lapk.org/ pmetrics.php. Accessed December 13, 2011.
13. Goutelle S, Bourguignon L, Maire PH, et al. Population modeling and Monte Carlo simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of rifampin in lungs. Antimicrob Agents Chemother. 2009;53:2974-2981.
14. Wang DD, Zhang S. Standardized visual predictive check versus visual predictive check for model evaluation. J Clin Pharmacol. 2012;52:39-54.
15. Mentré F, Escolano S. Prediction discrepancies for the evaluation of nonlinear mixed-effects models. J Pharmacokinet Pharmacodyn. 2006;33:345-367. (Pubitemid 44020385)
16. Wickham H. devtools: Tools to Make Developing R Code Easier. [computer program]. R package Version 0.4. The Comprehensive R Archive Network (CRAN); 2011. Available at: http://CRAN.R-project.org/package=devtools. Accessed December 14, 2011.
17. D'Agostino R. Transformation to normality of the null distribution of G 1. Biometrika. 1970;57:679-681.